secwatch / observer
8-K filed July 11, 2023, 7:59 PM ET ticker ERNA CIK 0000748592
leadership confidence high sentiment neutral materiality 0.45

Eterna Therapeutics appoints Binder and Wagner to Board; Singer and Cherington resign

Ernexa Therapeutics Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brant C. Binder

Director
ERNA · Ernexa Therapeutics Inc.
Effective
2023-07-06
Filed
July 11, 2023, 7:59 PM ET
On July 6, 2023, the Board appointed Mr. Brant C. Binder and Dr. Richard W. Wagner as directors, with effect immediately following the effectiveness of the resignations of Messrs. Singer and Cherington, to fill the vacancies on the Board created thereby.
Appointed

Richard W. Wagner

Director
ERNA · Ernexa Therapeutics Inc.
Effective
2023-07-06
Filed
July 11, 2023, 7:59 PM ET
On July 6, 2023, the Board appointed Mr. Brant C. Binder and Dr. Richard W. Wagner as directors, with effect immediately following the effectiveness of the resignations of Messrs. Singer and Cherington, to fill the vacancies on the Board created thereby.
Departed

Nicholas Singer

Director
ERNA · Ernexa Therapeutics Inc.
Effective
2023-07-06
Filed
July 11, 2023, 7:59 PM ET
On July 6, 2023 Nicholas Singer and Charles Cherington resigned from the Board of Directors (the “ Board ”) of Eterna Therapeutics Inc., a Delaware corporation (the “ Company ”).
Departed

Charles Cherington

Director
ERNA · Ernexa Therapeutics Inc.
Effective
2023-07-06
Filed
July 11, 2023, 7:59 PM ET
On July 6, 2023 Nicholas Singer and Charles Cherington resigned from the Board of Directors (the “ Board ”) of Eterna Therapeutics Inc., a Delaware corporation (the “ Company ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brant C. Binder was appointed as Director at Ernexa Therapeutics Inc..

Action
appointed
Role
Director
Exact text from the filing
On July 6, 2023, the Board appointed Mr. Brant C. Binder and Dr. Richard W. Wagner as directors, with effect immediately following the effectiveness of the resignations of Messrs. Singer and Cherington, to fill the vacancies on the Board created thereby.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard W. Wagner was appointed as Director at Ernexa Therapeutics Inc..

Action
appointed
Role
Director
Exact text from the filing
On July 6, 2023, the Board appointed Mr. Brant C. Binder and Dr. Richard W. Wagner as directors, with effect immediately following the effectiveness of the resignations of Messrs. Singer and Cherington, to fill the vacancies on the Board created thereby.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Nicholas Singer resigned as Director at Ernexa Therapeutics Inc..

Action
resigned
Role
Director
Exact text from the filing
On July 6, 2023 Nicholas Singer and Charles Cherington resigned from the Board of Directors (the “ Board ”) of Eterna Therapeutics Inc., a Delaware corporation (the “ Company ”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Charles Cherington resigned as Director at Ernexa Therapeutics Inc..

Action
resigned
Role
Director
Exact text from the filing
On July 6, 2023 Nicholas Singer and Charles Cherington resigned from the Board of Directors (the “ Board ”) of Eterna Therapeutics Inc., a Delaware corporation (the “ Company ”).
View on SEC.gov

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR
accession 0001140361-23-034072
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.